Gannet BioChem Advances Sustainability Goals Through TVA EnergyRight Strategic Energy Management Program

HUNTSVILLE, Ala., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Gannet BioChem, a leading specialty chemical Contract Development and Manufacturing Organization (CDMO), today announced progress toward its sustainability goals through participation in the TVA EnergyRight® Strategic Energy Management (SEM) program.

Gannet BioChem has committed to reducing Scope 1 and Scope 2 greenhouse gas emissions by 63% by 2035 from a 2020 baseline—a near-term target validated by the Science Based Targets initiative (SBTi). The TVA EnergyRight SEM program is helping the company translate that commitment into practical, measurable improvements at its Huntsville manufacturing facility.

Through the program, Gannet BioChem works with energy experts to assess facility operations, track performance and identify opportunities to reduce energy use. Monthly energy management and peer-learning sessions also allow the company to exchange best practices with other industrial manufacturers and build energy efficiency into everyday decision-making.

“Responsible manufacturing requires both ambitious goals and a practical plan for achieving them,” said Nicholas Shackley, Chief Executive Officer of Gannet BioChem. “Our work with TVA EnergyRight gives us the expertise, data and tools needed to make meaningful improvements while continuing to expand our capabilities as a CDMO. It also helps us provide customers with further confidence that their products are being manufactured with sustainability in mind.”

Initial projects have included an air-leak survey and air-compressor replacement, resulting in estimated annual energy savings of more than 150,000 kilowatt-hours. Additional initiatives currently underway include chiller upgrades, lighting improvements and the replacement of air-operated equipment, with further infrastructure projects planned for 2027.

The program also gives Gannet BioChem access to diagnostic tools and financial incentives that can improve the return on energy-efficiency investments. These resources help the company prioritize projects, uncover previously unidentified energy losses and connect reductions in electricity use with measurable greenhouse gas emissions data.

As part of its longer-term sustainability strategy, Gannet BioChem is also evaluating renewable energy certificates available through TVA, including considerations such as procurement volume, contract length and alignment with SBTi requirements.

Gannet BioChem will continue the conversation around sustainable pharmaceutical manufacturing at CPHI Milan, October 6–8, 2026. Companies interested in discussing their polymer, PEG reagent or bioconjugation programs with the Gannet BioChem team can visit GannetBioChem.com to book a meeting.

About Gannet BioChem
Gannet BioChem is a leading specialty CDMO focused on the development, scale-up, and manufacturing of activated polymers, including polyethylene glycol (PEG) reagents, which are critical components used in advanced biopharmaceutical, therapeutic, and medical device products. With more than 30 years of industry expertise, the company provides high-quality activated polymers, including PEG reagents, and related services to support customers from early development through commercialization. With a highly experienced scientific team, rigorous quality systems, and a strong track record supporting FDA, EU, and other regulatory agency approvals. Gannet BioChem delivers reliable, scalable solutions to meet the evolving needs of the global biopharmaceutical industry. For additional information, please visit GannetBioChem.com or follow us on LinkedIn. 

Contact:
Gabbie Burbanks
Marketing Manager
Gburbanks@gannetbiochem.com